Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

CVS-3983, a selective matriptase inhibitor, suppresses the growth of androgen independent prostate tumor xenografts.

Galkin AV, Mullen L, Fox WD, Brown J, Duncan D, Moreno O, Madison EL, Agus DB.

Prostate. 2004 Nov 1;61(3):228-35.

PMID:
15368474
2.

Antibody to vascular endothelial growth factor slows growth of an androgen-independent xenograft model of prostate cancer.

Fox WD, Higgins B, Maiese KM, Drobnjak M, Cordon-Cardo C, Scher HI, Agus DB.

Clin Cancer Res. 2002 Oct;8(10):3226-31.

3.

Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth.

Agus DB, Akita RW, Fox WD, Lewis GD, Higgins B, Pisacane PI, Lofgren JA, Tindell C, Evans DP, Maiese K, Scher HI, Sliwkowski MX.

Cancer Cell. 2002 Aug;2(2):127-37.

4.

Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke.

Huang J, Agus DB, Winfree CJ, Kiss S, Mack WJ, McTaggart RA, Choudhri TF, Kim LJ, Mocco J, Pinsky DJ, Fox WD, Israel RJ, Boyd TA, Golde DW, Connolly ES Jr.

Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11720-4.

5.

A potential role for activated HER-2 in prostate cancer.

Agus DB, Akita RW, Fox WD, Lofgren JA, Higgins B, Maiese K, Scher HI, Sliwkowski MX.

Semin Oncol. 2000 Dec;27(6 Suppl 11):76-83; discussion 92-100. Review.

PMID:
11236032
6.

Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1.

Amler LC, Agus DB, LeDuc C, Sapinoso ML, Fox WD, Kern S, Lee D, Wang V, Leysens M, Higgins B, Martin J, Gerald W, Dracopoli N, Cordon-Cardo C, Scher HI, Hampton GM.

Cancer Res. 2000 Nov 1;60(21):6134-41.

7.

Response of prostate cancer to anti-Her-2/neu antibody in androgen-dependent and -independent human xenograft models.

Agus DB, Scher HI, Higgins B, Fox WD, Heller G, Fazzari M, Cordon-Cardo C, Golde DW.

Cancer Res. 1999 Oct 1;59(19):4761-4.

8.

Hydroxylapatite augmentation of a maxillary defect.

Fox WD, Dolan EA, White JT.

Gen Dent. 1985 May-Jun;33(3):248-50. No abstract available.

PMID:
2993096

Supplemental Content

Support Center